Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jianlong Ke"'
Autor:
Lijuan Wang MD, Jianlong Ke MD, Cui Wang MD, Yaling Li MD, Guoyu Wu MD, Qian Ding MD, Qiuyue Luo MD, Rui Cai MD, Panpan Lv MD, Tingting Song MD, Shaoquan Xiong PhD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Purpose: To explore a new therapeutic option for patients with hepatocellular carcinoma (HCC), the efficacy and safety of a group of traditional Chinese medicines (Banxia XieXin recipe) as monotherapy for patients with advanced HCC was studied. Mater
Externí odkaz:
https://doaj.org/article/44c96db8e89d45ce91e44f2cbd6dcb74
Autor:
Shao-Quan Xiong, Xian-Ying Shen, Li-Juan Wang, Jin-Yang Wang, Xi Zhu, Wan Liao, Pan-Pan Lyu, Li-Zhu Lin, Cui Wang, Jianlong Ke, Yu Chen, Guang-Ping Li
Publikováno v:
Chinese Journal of Integrative Medicine. 27:502-508
Objective To study the use of Chinese medicine (CM) in cancer patients in southern China. Methods A total of 1,950 cancer patients finished questionnaires in four provinces in southern China. The survey included socio-demographic and clinical charact
Autor:
Cui Wang, Shao-Quan Xiong, Xian Ying Shen, Guang-Ping Li, Panpan Lv, Jianlong Ke, Jingyang Wang, Xi Zhu
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Purpose. The purpose of this paper is investigating the effect and mechanism of Shenfu injection (a Traditional Chinese Medicine injection form) on prevention and treatment of paclitaxel chemotherapy in peripheral nerve injury. Methods. Wistar rat do
Publikováno v:
Panminerva Medica.
Autor:
Panpan Lv, Ting-Ting Song, Yaling Li, Cui Wang, Jianlong Ke, Qian Ding, Shao-Quan Xiong, Qiuyue Luo, Li-Juan Wang, Rui Cai, Guoyu Wu
Publikováno v:
Integrative Cancer Therapies
Integrative Cancer Therapies, Vol 19 (2020)
Integrative Cancer Therapies, Vol 19 (2020)
Purpose: To explore a new therapeutic option for patients with hepatocellular carcinoma (HCC), the efficacy and safety of a group of traditional Chinese medicines (Banxia XieXin recipe) as monotherapy for patients with advanced HCC was studied. Mater
Publikováno v:
Panminerva Medica; Sep2023, Vol. 65 Issue 3, p436-437, 2p